Assessment of Retinal Pigment Epithelium Alterations and Chorioretinal Vascular Network Analyses in Patients under Treatment with BRAF/MEK Inhibitor for Different Malignancies: A Pilot Study

In the last two decades, an increasing number of so-called molecular-targeted therapies have become available for the treatment of patients with advanced malignancies. These drugs have included inhibitors of proteins in the MAPK pathway, such as BRAF and MEK inhibitors, which are characterized by a...

Descripción completa

Detalles Bibliográficos
Autores principales: Fasolino, Giuseppe, Awada, Gil, Moschetta, Laura, Koulalis, Jorgos Socrates, Neyns, Bart, Verhelst, Bert, Van Elderen, Peter, Nelis, Pieter, de Lichtbuer, Paul Cardon, Cools, Wilfried, Ten Tusscher, Marcellinus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918243/
https://www.ncbi.nlm.nih.gov/pubmed/36769861
http://dx.doi.org/10.3390/jcm12031214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918243/
https://www.ncbi.nlm.nih.gov/pubmed/36769861
http://dx.doi.org/10.3390/jcm12031214

Ejemplares similares